Xintian Pharmaceutical Industry (002873.SZ) released its half-year performance, with a net profit attributable to shareholders of 5.7661 million yuan, a decrease of 80.99%.

Financial news from CITIC Securities APP, Xintian Pharmaceutical (002873.SZ) released its semi-annual report for 2025. The company's operating income was 358 million yuan, a decrease of 18.88% year-on-year. Net profit attributable to shareholders of the listed company was 5.7661 million yuan, a decrease of 80.99% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.5795 million yuan, a decrease of 87.87% year-on-year. Basic earnings per share were 0.0236 yuan.